180 results on '"Watarai, Masato"'
Search Results
2. Prognostic impact of polypharmacy and discharge medications in octogenarians and nonagenarian patients with acute heart failure
3. Long-term outcomes of percutaneous revascularization for internal mammary artery–left anterior descending artery bypass failure
4. Impact of right coronary artery dominance on the long-term mortality in the patients with acute total/subtotal occlusion of unprotected left main coronary artery
5. Incidence and predictors of frailty progression among octogenarians with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
6. Clinical Impacts of Urinary Neutrophil Gelatinase-Associated Lipocalin in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
7. Clinical outcomes following percutaneous coronary intervention for bifurcation lesions: kissing balloon inflation vs. sequential dilation
8. Improved Renal Function After Percutaneous Coronary Intervention in Non-Dialysis Patients With Acute Coronary Syndrome and Advanced Renal Dysfunction
9. Utility of the Nutritional Screening in Predicting Adverse Outcome of Patients With Overweight/Obesity and Acute Heart Failure
10. Contrast-Induced Nephropathy and Long-Term Clinical Outcomes Following Percutaneous Coronary Intervention in Patients With Advanced Renal Dysfunction (Estimated Glomerular Filtration Rate
11. The association between oral health status and physical function in elderly patients with acute heart failure.
12. Young women undergoing percutaneous coronary intervention for spontaneous coronary artery dissection
13. Clinical characteristics and treatment of Spontaneous Coronary Artery Dissection in Young Women Undergoing Percutaneous Coronary Intervention
14. Prognostic impact of lipoprotein(a) levels during lipid management with statins after ST-elevation acute myocardial infarction
15. Two‐step changes in paced QRS morphology suggest capturing at different levels of posterior fascicle fibers during left bundle branch area pacing: A case report.
16. Prevalence of acute coronary syndrome during the pandemic of COVID-19 in the Tokai Region of Japan
17. Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction
18. Initiation and long-term use of tolvaptan for patients with worsening heart failure through hospital and clinic cooperation
19. Impact of Sitagliptin on Carotid Intima-Media Thickness in Patients With Coronary Artery Disease and Impaired Glucose Tolerance or Mild Diabetes Mellitus
20. Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease
21. Two‐step changes in paced QRSmorphology suggest capturing at different levels of posterior fascicle fibers during left bundle branch area pacing: A case report
22. A Comparative Study of Three Nutritional Risk/Screening Indices for Predicting Cardiac Events and Physical Functioning Among Patients with Acute Heart Failure
23. Differences in clinical outcomes between octogenarian and nonagenarian patients with acute heart failure.
24. High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima–media thickness
25. Clinical implications of severe sarcopenia in Japanese patients with acute heart failure
26. Association between serum urate level and carotid atherosclerosis: an insight from a post hoc analysis of the PRIZE randomised clinical trial
27. Clinical Implications of Oral Assessment In Elderly Patients With Acute Heart Failure: A Single-Center, Retrospective Study
28. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease
29. Clinical outcomes of rotational atherectomy in severely calcified in-stent restenosis: a single-center, retrospective study
30. Association between discharge destination and mid-term mortality in octogenarian patients with ST-elevation myocardial infarction
31. Clinical outcomes following percutaneous coronary intervention for bifurcation lesions: kissing balloon inflation vs. sequential dilation
32. Comparison Between Valsartan and Amlodipine Regarding Cardiovascular Morbidity and Mortality in Hypertensive Patients With Glucose Intolerance: NAGOYA HEART Study
33. Clinical impacts of cerebral microbleeds in patients with established coronary artery disease
34. Clinical Implications of Oral Assessment in Elderly Patients with Acute Heart Failure: A Single-center, Retrospective Study
35. Clinical characteristics and treatment of Spontaneous Coronary Artery Dissection in Young Women Undergoing Percutaneous Coronary Intervention
36. Optical Coherence Tomography-Guided Stent Implantation for Woven Coronary Artery Anomaly
37. Late Stent Thrombosis Concurrent With Stent Fracture at Calcified Nodule Lesion in Saphenous Vein Graft
38. Genetic risk and gene–environment interaction in coronary artery spasm in Japanese men and women
39. Long-term renal outcomes after elective percutaneous coronary intervention in patients with advanced renal dysfunction.
40. Clinical impacts of cerebral microbleeds in patients with established coronary artery disease.
41. Clinical outcomes after percutaneous coronary intervention in non-dialysis patients with acute coronary syndrome and advanced renal dysfunction.
42. Prognostic impact of lipoprotein(a) levels during lipid management with statins after ST-elevation acute myocardial infarction.
43. Prognostic Impact of the Preservation of Activities of Daily Living on Post-Discharge Outcomes in Patients With Acute Heart Failure
44. Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
45. Impact of red blood cell distribution width on non-cardiac mortality in patients with acute decompensated heart failure with preserved ejection fraction
46. Clinical Safety and Efficacy of Long-term Use of Tolvaptan after Discharge in Patients with Heart Failure
47. Safety and Efficacy of Long-Term Use of Tolvaptan in Patients With Heart Failure and Chronic Kidney Disease
48. Early Spontaneous Remission of Intramyocardial Dissecting Hematoma
49. Prognostic Impact of Change in Tolvaptan Usage across the Years for the Treatment of Heart Failure
50. Prognostic Value of Controlling Nutritional Status Score for Patients with Heart Failure with Preserved Ejection Fraction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.